CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 31 filers reported holding CERULEAN PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $14,596,000 | +446.5% | 3,287,529 | 0.0% | 15.10% | +428.3% |
| Q1 2017 | $2,671,000 | +14.7% | 3,287,529 | 0.0% | 2.86% | +3.5% |
| Q4 2016 | $2,328,000 | -32.4% | 3,287,529 | 0.0% | 2.76% | -24.0% |
| Q3 2016 | $3,442,000 | -50.6% | 3,287,529 | 0.0% | 3.63% | -51.4% |
| Q2 2016 | $6,970,000 | -21.8% | 3,287,529 | 0.0% | 7.48% | -12.1% |
| Q1 2016 | $8,909,000 | -3.2% | 3,287,529 | 0.0% | 8.51% | +17.7% |
| Q4 2015 | $9,205,000 | -23.5% | 3,287,529 | 0.0% | 7.23% | -11.8% |
| Q3 2015 | $12,032,000 | -20.4% | 3,287,529 | 0.0% | 8.20% | +21.5% |
| Q2 2015 | $15,123,000 | -48.9% | 3,287,529 | 0.0% | 6.74% | -49.0% |
| Q1 2015 | $29,621,000 | +44.9% | 3,287,529 | 0.0% | 13.23% | -18.2% |
| Q4 2014 | $20,448,000 | +47.4% | 3,287,529 | 0.0% | 16.18% | +51.1% |
| Q3 2014 | $13,873,000 | -27.2% | 3,287,529 | 0.0% | 10.71% | -31.1% |
| Q2 2014 | $19,068,000 | – | 3,287,529 | – | 15.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $6,970,000 | 7.48% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,047,000 | 5.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $954,000 | 0.25% |
| Deer VII & Co. Ltd. | 166,675 | $353,000 | 0.16% |
| Rock Springs Capital Management LP | 625,000 | $1,325,000 | 0.10% |
| Granahan Investment Management | 708,215 | $1,501,000 | 0.06% |
| Northeast Financial Consultants Inc | 20,000 | $42,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 202,623 | $430,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $34,000 | 0.01% |
| Alyeska Investment Group, L.P. | 319,289 | $677,000 | 0.01% |